Ablation of Intestinal Metaplasia Containing Dysplasia
Public ClinicalTrials.gov record NCT00282672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Ablation of Intestinal Metaplasia Containing Dysplasia (AIM Dysplasia Trial) A Multi-center, Randomized, Sham-Controlled Trial: Protocol Amendment to Extend Follow-up to 5 Years
Study identification
- NCT ID
- NCT00282672
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Medtronic - MITG
- Industry
- Enrollment
- 127 participants
Conditions and interventions
Conditions
Interventions
- Ablation System plus anti-secretory medication Device
- Sham procedure plus anti-secretory medication Device
Device
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2006
- Primary completion
- Mar 31, 2014
- Completion
- Jul 31, 2014
- Last update posted
- Nov 5, 2017
2006 – 2014
United States locations
- U.S. sites
- 19
- U.S. states
- 16
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Scottsdale | Scottsdale | Arizona | 85259 | — |
| University of Arizona, VAMC | Tucson | Arizona | 85723 | — |
| UC Irvine Medical Center | Orange | California | 92868 | — |
| Mayo Clinic - Jacksonville | Jacksonville | Florida | 32224 | — |
| Harvard, VA Boston Healthcare W Roxbury | West Roxbury | Massachusetts | 02132 | — |
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | — |
| University of Kansas School of Medicine - Veterans Affairs Medical Center | Kansas City | Missouri | 64128 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| UNC Center for Functional GI & Motility Disorders | Chapel Hill | North Carolina | 27599 | — |
| University Hospitals of Cleveland | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Gastrointestinal Associates | Knoxville | Tennessee | 37909 | — |
| VAMC Dallas | Dallas | Texas | 75216 | — |
| Tacoma Digestive Disease Research Center | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00282672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00282672 live on ClinicalTrials.gov.